Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10981886 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Patent 10981886 was granted and assigned to ADT Pharmaceuticals, LLC on April, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

ADT Pharmaceuticals, LLC

Current Assignee

‌

ADT Pharmaceuticals, LLC

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109818860

Patent Inventor Names

Gary A. Piazza0

Adam B. Keeton0

Michael R. Boyd0

Xi Chen0

Date of Patent

April 20, 2021

Patent Application Number

165938060

Date Filed

October 4, 2019

Patent Citations

‌

US Patent 10526307 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Patent Citations Received

‌

US Patent 11407727 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

‌

US Patent 11680073 Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

Patent Primary Examiner

‌

Amanada L. Aguirre

Patent abstract

Disclosed are compounds, for example, compounds of formula I,

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10981886 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API